Table 2.
Demographics and Comorbidities of the Study Population
| Control | HFpEF | HFrEF | Control vs. HFpEF p-value |
Control vs. HFrEF p-value |
HFpEF vs. HFrEF p-value |
||
|---|---|---|---|---|---|---|---|
| Race | White | 134(63.5%) | 222(62.2%) | 123(56.6%) | 0.69 | 0.29 | 0.15 |
| Black | 69(32.7%) | 125(35%) | 82(37.4%) | ||||
| Asian | 1(.5%) | 3(.84%) | 4(1.8%) | ||||
| Other | 7(3.3%) | 7(1.96%) | 10(4.6%) | ||||
| Sex | Male | 120(56.9%) | 185(51.8%) | 155(70.8%) | 0.26 | 0.004 | <.0001 |
| Female | 91(43.1%) | 172(48.2%) | 64(29.2%) | ||||
| Type 2 Diabetes (%) | 33(15.6%) | 163(45.7%) | 75(34.2%) | <.0001 | <.0001 | 0.0069 | |
| Hypertension (%) | 103(48.8%) | 283(79.2%) | 161(73.5%) | <.0001 | <.0001 | 0.11 | |
| Hyperlipidemia (%) | 99(46.9%) | 260(72.8%) | 157(71.7%) | <.0001 | <.0001 | 0.76 | |
| Atrial Fibrillation (%) | 16(7.6%) | 202(56.6%) | 100(45.7%) | <.0001 | <.0001 | 0.011 | |
| Chronic Kidney Disease (%) | 13(6.2%) | 100(28%) | 77(35.2%) | <.0001 | <.0001 | 0.07 | |
| COPD (%) | 16(7.6%) | 100(28%) | 40(18.3%) | <.0001 | 0.001 | 0.008 | |
| Any Cancer (%) | 6(2.8%) | 98(27.5%) | 49(22.4%) | <.0001 | <.0001 | 0.2 | |
| Prior MI (%) | 4(1.9%) | 44(12.3%) | 50(22.8%) | <.0001 | <.0001 | 0.001 | |